112 Pill - beige round, 8mm
Generic Name: sitagliptin
Pill with imprint 112 is Beige, Round and has been identified as Januvia 50 mg. It is supplied by Merck & Company Inc.
Januvia is used in the treatment of Type 2 Diabetes and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 112
Januvia
- Generic Name
- sitagliptin
- Imprint
- 112
- Strength
- 50 mg
- Color
- Beige
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Merck & Company Inc.
- Inactive Ingredients
-
calcium phosphate dibasic anhydrous,
croscarmellose sodium,
magnesium stearate,
microcrystalline cellulose,
ferric oxide red,
sodium stearyl fumarate,
magnesium silicate,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00006-0112 | Merck |
| 54868-6031 (Discontinued) | Physicians Total Care Inc. (repackager) |
Related images for "112"
More about Januvia (sitagliptin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (139)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: dipeptidyl peptidase 4 inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.